NEWS
NORMAN, OKLA. – Two proposals have been selected for funding through the Office of the Vice President for Research and Partnerships’ Strategic Equipment Investment Program. Equipment purchased under this program is expected to significantly advance research and creative activities across the university.
SEIP provides funding for the acquisition of strategic research equipment that enhances the capabilities and national competitiveness of interdisciplinary teams. The selected projects are expected to “provide new opportunities for advancing the team’s ability to achieve new goals in terms of creativity, discovery, innovation and competitiveness in securing external funding.”
The awarded proposals are:
This is the eighth offering of the Strategic Equipment Investment Program. Learn more about SEIP and other internal seed funding opportunities at ou.edu/research.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
A University of Oklahoma physician-researcher recently received $2.9 million in funding from the National Cancer Institute to study whether RedHill Biopharma’s drug opaganib, given after CAR T-cell therapy, can help the immune cells fight cancer more effectively.
A protein called Miro1 found at elevated levels in the skeletal muscle of people with type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications.
Plane spotters who photograph aircraft at the University of Oklahoma’s Max Westheimer Airport will bring their photography into its lobby this November as part of a growing program showcasing Oklahoma artists.
